Humanized multi-organoid models for translational drug discovery

abc biopply is a Swiss-based organoid CRO providing advanced humanized multi-organoid models powered by the proprietary 3D CoSeedis™ technology platform.

Our systems enable the generation of highly standardized and scalable multi-tissue disease models that recapitulate complex human microenvironments. These models support drug discovery and preclinical research by enabling:

• efficacy and potency testing in human-relevant systems

• mechanism-of-action and resistance studies

• safety and toxicity assessment in complex tissue environments

• biomarker discovery and translational research

The platform is compatible with a wide range of therapeutic modalities, including small molecules, biologics, cell and gene therapies, and mRNA-based approaches.

We collaborate with pharmaceutical companies, biotech firms, and CRO partners to integrate organoid-based models into discovery workflows, supporting earlier decision-making and improved predictability of clinical outcomes.